These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20702477)

  • 1. Quetiapine-associated cholestasis causing lipoprotein-X and pseudohyponatraemia.
    Klinke JA; Shapira SC; Akbari E; Holmes DT
    J Clin Pathol; 2010 Aug; 63(8):741-3. PubMed ID: 20702477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohyponatraemia in a patient with obstructive jaundice.
    le Riche M; Burgess LJ; Marais AD
    Clin Chim Acta; 2006 Apr; 366(1-2):357-60. PubMed ID: 16289427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury: hepatotoxicity of quetiapine revisited.
    Shpaner A; Li W; Ankoma-Sey V; Botero RC
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1106-9. PubMed ID: 19047843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone- and quetiapine-induced cholestasis.
    Wright TM; Vandenberg AM
    Ann Pharmacother; 2007 Sep; 41(9):1518-23. PubMed ID: 17666578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].
    van den Heuvel OA; Bet PM; van Dam EW; Eeckhout AM
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1944-8. PubMed ID: 16999280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quetiapine-induced leucopenia].
    Penninga EI; Dalhoff KP; Lykkegaard SE
    Ugeskr Laeger; 2008 Sep; 170(37):2892. PubMed ID: 18796287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis].
    Calvo C; Arroqui I
    Rev Med Chil; 1984 Mar; 112(3):233-7. PubMed ID: 6473964
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical usefulness of lipoprotein-X (LP-X) as an indicator of intrahepatic cholestasis in viral hepatitis].
    Szczotka W; Sawaryn T; Wiczkowski A
    Wiad Lek; 1986 Jun; 39(11):739-48. PubMed ID: 3776191
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver.
    Zidan H; Lo S; Wiebe D; Talano J; Alemzadeh R
    Pediatr Blood Cancer; 2008 Jun; 50(6):1280-1. PubMed ID: 18286546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis secondary to quetiapine.
    Velasco-Montes J; Oriñuela-González I; Sanjuán-López AZ
    Actas Esp Psiquiatr; 2012; 40(2):97-9. PubMed ID: 22508075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura associated with quetiapine.
    Huynh M; Chee K; Lau DH
    Ann Pharmacother; 2005; 39(7-8):1346-8. PubMed ID: 15914516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures associated with quetiapine treatment.
    Dogu O; Sevim S; Kaleagasi HS
    Ann Pharmacother; 2003 Sep; 37(9):1224-7. PubMed ID: 12921503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine-associated dysphagia.
    Kohen I; Lester P
    World J Biol Psychiatry; 2009; 10(4 Pt 2):623-5. PubMed ID: 18615368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein-X as an indicator of cholestasis in liver and biliary tract diseases].
    Sawaryn T
    Wiad Lek; 1984 Oct; 37(19):1522-7. PubMed ID: 6396957
    [No Abstract]   [Full Text] [Related]  

  • 17. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease.
    Prueter C; Habermeyer B; Norra C; Kosinski CM
    Mov Disord; 2003 Jun; 18(6):712-3. PubMed ID: 12784279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature.
    Hussain I; Ahmad Z; Garg A
    J Clin Lipidol; 2015; 9(2):260-4. PubMed ID: 25911084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein X in the cholestatic syndrome.
    Vrublovský P; Kubícek R; Seidlová V; Smoldas J; Zák J
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():423-6. PubMed ID: 2977506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.